Atlas Trials

Effect of RIC on 2,3-BPG in Erythrocyte (RIC-BPG)

Clinical trial NCT04192578 · UNKNOWN

Trial details

NCT number
NCT04192578
Sponsor
Capital Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
2,3-Bisphosphoglycerate
Start date
2021-01-15
Primary completion
2021-03-15
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.